Boundless Bio, Inc. (BOLD) — Financial statements
Income statement, balance sheet, and cash flow for Boundless Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 1↑15.2% | 1 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -1↓15.2% | -1 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 45↓18.9% | 55↑29.6% | 43↑14.7% | 37↑92.8% | 19 | |
| General & Administrative Expenses | 19↑3.9% | 18↑48.0% | 12↑30.6% | 9↑54.6% | 6 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 19↑3.9% | 18↑48.0% | 12↑30.6% | 9↑54.6% | 6 | |
| Other Expenses | -1↓15.2% | -1 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 62↓13.7% | 72↑31.7% | 55↑17.9% | 46↑83.7% | 25 | |
| Total Costs & Expenses | 64↓13.3% | 73↑33.7% | 55↑17.9% | 46↑83.7% | 25 | |
| Operating Results | ||||||
| Operating Income | -64↑13.3% | -73↓33.7% | -55↓17.9% | -46↓83.7% | -25 | |
| Depreciation & Amortization | 1↑15.2% | 1↑13.5% | 0.96↑1.6% | 0.94↑38.1% | 0.68 | |
| EBITDA | -62↑3.1% | -64↓19.4% | -54↓18.3% | -46↓84.9% | -25 | |
| EBIT | -64↑2.8% | -65↓19.3% | -55↓17.9% | -46↓83.7% | -25 | |
| Interest & Other Income | ||||||
| Net Interest Income | 5↓32.1% | 8↑49.4% | 5↑690.7% | 0.67↑595.8% | 0.10 | |
| Interest Income | 5↓32.1% | 8↑49.4% | 5↑690.7% | 0.67↑595.8% | 0.10 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -8 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 5↓32.2% | 8↑47.4% | 5↑844.0% | 0.57↑524.2% | 0.09 | |
| Income Before Tax | -58↑11.0% | -65↓32.2% | -49↓7.7% | -46↓82.1% | -25 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -58↑11.0% | -65↓32.2% | -49↓7.7% | -46↓82.1% | -25 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -58↑11.0% | -65↓32.2% | -49↓7.7% | -46↓82.1% | -25 | |
| Bottom-Line Net Income | -58↑11.0% | -65↓32.2% | -49↓7.7% | -46↓82.1% | -25 | |
| EPS (Basic) | -2.60↑32.5% | -3.85↓73.4% | -2.22↓7.8% | -2.06↓82.3% | -1.13 | |
| EPS (Diluted) | -2.60↑32.5% | -3.85↓73.4% | -2.22↓7.8% | -2.06↓82.3% | -1.13 | |
| Weighted Average Shares | 22↑31.7% | 17↓23.6% | 22↑0.0% | 22↑0.0% | 22 | |
| Weighted Average Diluted Shares | 22↑31.7% | 17↓23.6% | 22↑0.0% | 22↑0.0% | 22 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.